Cornerstone Planning Group LLC Charles River Laboratories International, Inc. Transaction History
Cornerstone Planning Group LLC
- $322 Billion
- Q1 2024
A detailed history of Cornerstone Planning Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 40 shares of CRL stock, worth $7,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 75
46.67%
Holding current value
$7,986
Previous $17.7 Million
47.33%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.21 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.03 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$418 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$375 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$302 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...